Mubadala – Talk Bio

Actionable Insights Powered by AI

Tenvie Therapeutics Launches with $200 Million to Revolutionize Neurological Disease Treatment

4 months ago talkbio0Tagged Arch of foot, Denali, F-Prime Capital, Mubadala, Neurological diseases, Partner in relationship, small molecule therapies, Tenvie, venture

Tenvie Therapeutics, neurological diseases, small molecule therapies, Denali Therapeutics, ARCH Venture Partners, F-Prime Capital, Mubadala Capital

UCB Divests Mature Neurology and Allergy Portfolio in China for $680M

8 months ago talkbio0Tagged CBC Group, China, Complete Blood Count, innovation, Mubadala, Neurology speciality, strategic partnerships, UCB

UCB, China, neurology, allergy, divestment, CBC Group, Mubadala, pharmaceuticals, innovation, strategic partnerships